ENKAM PHARMACEUTICALS AS has a total of 49 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SMYTH MARK S, SANDOZ PHARMA UK and ARAIM PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | Canada | 7 | |
#4 | Australia | 6 | |
#5 | China | 4 | |
#6 | Brazil | 3 | |
#7 | Mexico | 3 | |
#8 | United States | 3 | |
#9 | Israel | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Berezin Vladimir | 42 |
#2 | Bock Elisabeth | 40 |
#3 | Albrechtsen Morten | 11 |
#4 | Kiselyov Vladislav V | 6 |
#5 | Holm Arne | 5 |
#6 | Holm Arne Valdemar | 5 |
#7 | Olsen Marianne | 4 |
#8 | Soroka Vladislav | 4 |
#9 | Soroka Vladyslav | 3 |
#10 | Poulsen Flemming Martin | 3 |
Publication | Filing date | Title |
---|---|---|
WO2007110079A2 | Targeted delivery of fgfr ligands into the brain | |
WO2007045247A2 | Fibroblast growth factor receptor-derived peptides | |
EP1940873A2 | Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 | |
AU2005254613A1 | FGFR binding peptides | |
MXPA06014402A | Heparin binding peptide. | |
CN1886422A | A method of modulating cell survival, differentiation and/or synaptic plasticity | |
MXPA06001501A | Compounds comprising lpa. | |
CN1863820A | Compounds comprising lpa | |
AU2003287918A1 | Method of modulation of interaction between receptor and ligand | |
CA2459937A1 | Ncam binding compounds | |
EP1434798A2 | Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells | |
AU5654502A | Survical promoting NCAM binding and NCAM ligand biding compounds |